0.1725
price up icon0.82%   0.0014
after-market Handel nachbörslich: .17 -0.0025 -1.45%
loading

Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.39
- - - -
Operating Expenses
46.88%
8.121
5.529 3.71 3.67 4.887
Benefits Costs and Expenses
9.237
- - - -
Costs And Expenses
9.237
- - - -
Operating Income/Loss
39.83%
-7.731
-5.529 -3.71 -3.67 -4.887
Nonoperating Income/Loss
21.17%
-1.116
-0.921 -1.121 -2.887 -1.071
Income/Loss From Continuing Operations Before Tax
37.16%
-8.847
-6.45 -4.831 -6.557 -5.958
Income Tax Expense/Benefit
123.73%
0.132
0.059 0.06 0.025 0.136
Income/Loss From Continuing Operations After Tax
37.95%
-8.979
-6.509 -4.891 -6.582 -6.094
Net Income/Loss
37.95%
-8.979
-6.509 -4.891 -6.582 -6.094
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14.69%
45.80
39.94 34.06 2.3463 20.04
Diluted Average Shares
14.69%
45.80
39.94 34.06 2.3463 20.04
Basic Earnings Per Share
25.00%
-0.20
-0.16 -0.14 -0.21 -0.30
Diluted Earnings Per Share
25.00%
-0.20
-0.16 -0.14 -0.21 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):